x

75% of people globally want unbiased news (Pew Research) but are concerned they're not getting that.

Get balanced coverage with Symby. See how stories are covered across diverse outlets and spot when one side covers a story the other skips.

PODCAST

Data in Biotech

Data in Biotech is a fortnightly podcast exploring how companies leverage data to drive innovation in life sciences. Every two weeks, Ross Katz, Principal and Data Science Lead at CorrDyn, sits down with an expert from the world of biotechnology to understand how they use data science to solve technical challenges, streamline operations, and further innovation in their business. You can learn more about CorrDyn - an enterprise data specialist that enables excellent companies to make smarter

science life sciences

All Episodes

00:45:24

Jaidev Chakka on building the future of bioprinted...

Data in Biotech ·

2025/12/26

In this episode of Data in Biotech, Ross Katz chats with Jaidev Chakka, Principal Scientist at the University of Mississippi School of Pharmacy, about how 3D bioprinting and AI are reshaping pharmaceutical manufacturing. They explore the development of custom scaffolds for tissue engineering, the integration of gene delivery systems, and how data-driven approaches are enabling smarter, more scalable solutions in personalized medicine.What you'll learn in this episode: >> How 3D

en

00:25:34

From screening to IND: How Veloxity accelerates...

Data in Biotech ·

2025/12/22

In this episode of Data in Biotech, Ross Katz sits down with Callie Celichowski and Isa Kupke from Veloxity Labs to discuss how their CRO leverages speed, precision, and innovation to support drug development. Learn how they use mass spectrometry, cloud-based infrastructure, and hands-on client partnerships to drive rapid, high-quality bioanalytical insights that support everything from preclinical studies to FDA submissions. What you'll learn in this episode: >> Why "speed with

en

00:32:31

Revolutionizing bioanalysis with high-resolution mass...

Data in Biotech ·

2025/12/15

In this episode of Data in Biotech, host Ross Katz sits down with Eshani Galermo, Staff Scientist at SCIEX, to explore the next generation of mass spectrometry in pharma and biopharma. Eshani explains how innovations like the ZenoTOF 8600 are redefining sensitivity, selectivity, and workflow efficiency in bioanalytical chemistry. Discover how high-resolution accurate mass (HRAM) systems are unlocking new capabilities in drug discovery, clinical studies, and regulatory science.What you'll

en

00:51:14

Mastering solubility and stability in drug...

Data in Biotech ·

2025/12/03

In this episode of Data in Biotech, Ross Katz chats with Wesley Tatum, Principal Engineer at Serán BioScience, about the intricacies of formulating low-solubility drug products. They explore the science behind amorphous solid dispersions, how data informs formulation choices, and why balancing performance, manufacturability, and stability is critical in modern drug development.What you'll learn in this episode: >> How amorphous solid dispersions improve solubility and stability in drug

en

00:35:48

Applying ML/AI to Drug Development with Anil Kane

Data in Biotech ·

2025/11/26

Dr. Anil Kane, Global Head of Technical & Scientific Affairs at Thermo Fisher Scientific, joins Ross Katz to discuss how AI, machine learning, and digital tools are reshaping drug development. From predictive modeling for formulation to digital manufacturing efficiencies, discover how data-driven approaches are reducing time, cost, and complexity in pharma innovation.What You'll Learn in This Episode: >> How predictive modeling eliminates trial-and-error in drug

en

00:49:51

Streamlining bioanalytical workflows with Watson LIMS...

Data in Biotech ·

2025/11/20

In this episode of Data in Biotech, host Ross Katz sits down with John Liberty, Senior Bioanalysis Technical Sales Consultant at Thermo Fisher Scientific. They dive deep into how Watson LIMS™ supports regulated bioanalysis workflows, the evolving role of lab automation, and how Connect Enterprise aims to unify biotech digital ecosystems.What you'll learn in this episode: >> Why Watson LIMS is purpose-built for bioanalysis and how it enhances compliance and data traceability. >>

en

00:52:17

Scaling AI infra in biotech with Saturn Cloud and Nebius

Data in Biotech ·

2025/11/05

Discover how biotech and healthcare teams are fast-tracking research and development through AI and high-performance cloud infrastructure. Ross Katz sits down with Hugo Shi of Saturn Cloud and Ilya Burkov of Nebius to explore scalable, secure solutions for GPU-heavy AI workloads. From compliance to cost savings, this episode unpacks what it takes to innovate at scale in life sciences.What You'll Learn in This Episode: >> Why AI workloads in biotech demand specialized

en

00:49:08

The Future of Co-Folding and Federated Learning with...

Data in Biotech ·

2025/10/22

Robin Rohm, CEO and Co-Founder of Apheris, joins Ross Katz to explore how federated learning is unlocking secure, cross-company collaboration in pharma. Discover how Apheris is enabling biopharma leaders to train cutting-edge co-folding models without sharing sensitive data, why AlphaFold 3 wasn’t enough, and what OpenFold 3 means for the future of AI in drug discovery.What You'll Learn in This Episode >> Why federated learning is a game-changer for pharma data sharing and AI-driven

en

00:56:24

Automating biopharma knowledge work with Convoke

Data in Biotech ·

2025/10/01

What if biotech teams could automate the most information-intensive parts of bringing a drug to market? In this episode of Data in Biotech, host Ross Katz speaks with Convoke co-founders Alex Telford and Maged Ahmed about building an AI-native knowledge acquisition and curation system for biopharma. Learn how they're transforming clinical research, regulatory writing, and competitive intelligence using LLMs, semantic search, and scalable data infrastructure.What You'll Learn in This

en

00:40:44

How Eli Lilly’s new platform TuneLab codevelops AI...

Data in Biotech ·

2025/09/17

Dr. Aliza Apple, VP of Catalyze360 AI/ML at Eli Lilly, joins Ross Katz to unveil TuneLab—a first-of-its-kind federated learning platform accelerating preclinical drug discovery. Learn how Lilly’s billion-dollar models are empowering early-stage biotechs, the science behind federated learning, and what this means for the future of pharmaceutical R&D.What You'll Learn in This Episode: >> How Eli Lilly's TuneLab democratizes access to proprietary AI models trained on decades of

en

00:46:33

Inside Merck's Computational Biology Approach with...

Data in Biotech ·

2025/09/03

In this episode of Data in Biotech, host Ross Katz talks with Jesper Ryge, Director of Computational Biology at Merck Germany. Jesper shares his journey from neuroscience labs to leading computational teams, offering deep insights into disease modeling, target discovery, and multi-omics integration. Discover how AI and spatial transcriptomics are shaping the future of pharma R&D.What You'll Learn in This Episode >> How single-cell and spatial transcriptomics enhance disease

en

00:31:54

Where Biotech Innovation Really Happens: 50th Episode...

Data in Biotech ·

2025/08/20

To mark our 50th episode, host Ross Katz brings back three visionary leaders—Dave Johnson (Dash Bio), Wolfgang Halter (Merck Life Science), and Jacob Oppenheim (RAVen)—together for a reflection on the evolution of biotech. They unpack the realities behind AI hype, the future of data-driven innovation, and what’s really changing in drug development.What You'll Learn in This Episode: >> Where real innovation is emerging across startups, big tech, and academia >> The biggest

en

00:49:40

How BioRaptor is Modernizing Bioprocessing Workflows

Data in Biotech ·

2025/07/31

In this episode of Data in Biotech, Yaron David, CTO and Co-Founder of BioRaptor, joins host Ross Katz to explore how biotech companies can gain a holistic view of bioprocessing through real-time data integration, visualization, and modeling. Learn how BioRaptor’s full-stack platform helps scientists replace clunky spreadsheets with actionable insights—accelerating experiments and optimizing yields.What You'll Learn in This Episode: >> Why Excel is holding back innovation in

en

00:45:17

Modernizing Clinical Data Analysis with Jesse Paquette

Data in Biotech ·

2025/07/11

In this episode of Data in Biotech, Jesse Paquette, co-founder and Chief Science Officer of Tag.bio, joins Ross Katz to explore how data mesh architecture and FAIR data principles are transforming clinical and research workflows in life sciences. From harmonizing legacy systems to enabling AI-readiness, Jesse shares how Tag.bio empowers domain experts to make data-driven decisions faster and more effectively.What You'll Learn in This Episode: >> How Tag.bio leverages data mesh and

en

00:55:17

Building Scalable Data Platforms for Spatial Biology...

Data in Biotech ·

2025/06/25

In this episode of Data in Biotech, Ross Katz sits down with Kenny Workman, co-founder and CTO of LatchBio, to unpack how biotech’s data infrastructure must evolve to meet the demands of next-gen assays. From scalable workflows to high-performance visualization tools, Kenny breaks down the shift from traditional biotech to a future defined by data-driven research and agile cloud platforms.What You'll Learn in This Episode: Why spatial biology and high-throughput assays require new data

en

01:00:25

Solving Chronic Disease with Life Insurance and Data...

Data in Biotech ·

2025/06/11

Entrepreneur Jeremy Shane joins host Ross Katz to discuss Life for Health, a revolutionary framework aiming to tackle chronic disease through the integration of life insurance, longitudinal data, and preventative care. From drug discovery feedback loops to outcomes-based pricing, Shane outlines a bold new path for biotech and healthcare convergence. What You'll Learn in This Episode: Why today's healthcare system fails chronic disease patients and how Life for Health aims to fix it.How

en

00:58:54

How Etiome Is Redefining Preemptive Medicine with...

Data in Biotech ·

2025/05/29

In this episode of Data in Biotech, host Ross Katz sits down with Scott Lipnick, Co-Founder and President of Etiome, to explore how preemptive medicine is changing the way biotech approaches therapeutic modeling and intervention. Discover how Etiome’s recently launched, AI-driven platform is built to detect disease earlier, identify precise biomarkers, and create stage-specific treatments—all before symptoms arise. It’s a visionary approach to healthcare focused on preserving health, not

en

00:47:17

Transforming Houseplants with Synthetic Biology with...

Data in Biotech ·

2025/05/14

In this episode of Data in Biotech, host Ross Katz speaks with Patrick Torbey, CEO and Co-Founder of Neoplants, about using genetic engineering and microbiome innovation to tackle indoor air pollution. Patrick explains how Neoplants is turning everyday houseplants into powerful air purifiers using synthetic biology, offering insights into VOC degradation, enzyme pathways, and data-driven R&D.What You'll Learn in This Episode: How genetically modified plants and microbiomes can reduce

en

00:59:02

How Phage Therapy is Scaling to Meet Antibiotic...

Data in Biotech ·

2025/04/30

Phage therapy is stepping into the spotlight as antibiotic resistance rises - and Jessica Sacher is helping lead the charge. In this episode, Ross Katz speaks with Jessica, Co-Founder of Phage Directory and Staff Scientist at Stanford, about sourcing phages, operationalizing therapy, and predicting efficacy through data. This conversation explores how personalized phage therapy works, its scalability, and the data challenges shaping its future.What You'll Learn in This Episode: Why phage

en

00:46:54

Targeting Transcription Factors with AI, featuring...

Data in Biotech ·

2025/04/16

How do you drug the undruggable? In this episode of Data in Biotech, Ross Katz sits down with Will Fondrie, Head of Data Science and Engineering at Talus Bio, to explore how machine learning, mass spectrometry, and innovative computational models are transforming drug discovery. Learn how Talus Bio is targeting transcription factors—once considered out of reach—with scalable, high-impact data science.What You'll Learn in This Episode Why transcription factors are historically hard to drug

en

61 results

Similar Podcasts

Classic Radio Science Fiction

solgoodmedia.com

Mission to Mars

Inception Point Ai

The 365 Days of Astronomy

365DaysOfAstronomy.org

Creek Devil

william Jevning

UFO Chronicles Podcast

Nik Hunter